CD ComputaBio provides clients with a full range of services from peptide drug target discovery to preclinical studies for the efficient development of novel drugs.
The use of advanced computational methods in the field of peptide drug design provides innovative approaches to R&D challenges and facilitates the development of novel peptides.
CD ComputaBio offers computation-driven peptide design services to research institutions, pharmaceutical, and biotechnology companies.